I agree davy its been a long time since any update. But have a look back previous announcements, and they do say both trials are on hold while they are redesigned.
The AML trial at the moment is also redesigned since it started due to the interaction of PTX 200 and the combined chemo. I do wonder if this trial is helping with the redesign for Breast and Ovarian trials? All based on guess work with no real supporting evidence.
Still with a market cap around $aud60 million, with PTX 200 AML and PTX 100 trials underway its an undervalued company. Add the Breast and ovarian as further trials in the future, not to mention Omnicar, the company has huge potential.
As superT has stated PTX100 alone has huge potential.
- Forums
- ASX - By Stock
- PTX
- Ann: PTX-200 AML Trial Progresses to Higher Dose
Ann: PTX-200 AML Trial Progresses to Higher Dose, page-25
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.5¢ |
Change
-0.002(4.26%) |
Mkt cap ! $36.23M |
Open | High | Low | Value | Volume |
4.5¢ | 4.6¢ | 4.5¢ | $7.401K | 163.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 74868 | 4.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.7¢ | 52776 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 74868 | 0.045 |
5 | 354841 | 0.044 |
3 | 557800 | 0.043 |
4 | 168809 | 0.042 |
6 | 477461 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 52776 | 3 |
0.048 | 155000 | 1 |
0.049 | 114091 | 2 |
0.050 | 427445 | 9 |
0.052 | 500000 | 1 |
Last trade - 10.31am 10/09/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |